MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases - Trial NCT06208397
Access comprehensive clinical trial information for NCT06208397 through Pure Global AI's free database. This phase not specified trial is sponsored by Shengjing Hospital and is currently Recruiting. The study focuses on Metastatic Colorectal Cancer. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Magnetic Resonance Elastography and routine MRI
Observational
diagnostic test
Sponsor & Location
Shengjing Hospital
Timeline & Enrollment
N/A
Dec 24, 2023
Dec 24, 2025
Primary Outcome
Radiological assessment of CRLM
Summary
The goal of this study is to investigate the value of MR elastography-based SII as a means of
 detecting HGP noninvasively in patients with pathology-proven CRLM. MRE will provide a direct
 measure of tumor-liver adhesion to investigate the relationship between imaging findings and
 pathophysiological changes in the Liver.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06208397
Non-Device Trial